emilpharma 
Dealstreet

ELP acts on Somerset Indus Capital Partners' investment in Emil Pharmaceutical

The deal amount remains undisclosed.

Bar & Bench

Somerset Indus Capital Partners has made an investment in Emil Pharmaceutical Industries Pvt Ltd, a pharmaceutical contract development and manufacturing organization. This marks the fund’s fifth overall and second pharmaceutical investment from its Fund II.

Economic Laws Practice advised Somerset Indus Capital Partners in this deal.

The transaction team consisted of Vinay Butani (Partner), Taskeen Hamid (Counsel) and Vinit Shah (Senior Associate).

If you would like your Deals, Columns, Press Releases to be published on Bar & Bench, please fill in the form available here.

Also Read

Should we monitor handkerchief use next? Supreme Court rejects PIL on eco-friendly disposal of advocates’ bands

How AI is Shaping Your Online Reputation: Commwiser’s Primary Research on Indian Law Firms & Lawyers

Mode of reaching temple not essential religious practice: Kerala HC refuses early opening of forest path to Sabarimala

Patiala House and Saket courts in Delhi evacuated after bomb scare

Don't need CJI or Centre approval for rules allowing entry of foreign law firms: BCI to Delhi High Court

SCROLL FOR NEXT